July 13, 2017 / 9:59 AM / a month ago

BRIEF-Vista Pharmaceuticals receives warning letter from U.S. FDA

July 13 (Reuters) - Vista Pharmaceuticals Ltd

* Says US FDA has issued a warning letter no.320-17-40

* Says shall respond with complete details of remedial actions to US FDA before stipulated date

* Says on account of this there is no disruption of operations and no revenue loss is envisaged Source text - (bit.ly/2uUrMm4) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below